News from stiefel, a gsk company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Toronto:AW.UN)

Sep 28, 2012, 08:35 ET

Stiefel receives US FDA approval of Sorilux™ Foam, 0.005% for topical treatment of plaque psoriasis of the scalp

 Stiefel, a GSK (NYSE:GSK) company, today announced that the US Food and Drug Administration has approved a supplemental New Drug Application...

May 31, 2012, 20:01 ET

Stiefel, ein GSK-Unternehmen, geht Vertrag mit Welichem Biotech, Inc. über die Akquisition eines neuartigen topischen Wirkstoffes gegen Psoriasis und atopische Dermatitis ein

Stiefel, ein Unternehmen der GSK-Gruppe (NYSE:GSK), und Welichem Biotech, Inc. (WBI:CN) haben einen Vertrag über die Akquisition durch Stiefel...

May 31, 2012, 17:28 ET

Stiefel, una compañía GSK, entra en negociaciones con Welichem Biotech, Inc. para adquirir un nuevo agente

- Stiefel, una compañía GSK, entra en negociaciones con Welichem Biotech, Inc. para adquirir un nuevo agente de uso tópico para la...

May 31, 2012, 08:32 ET

Stiefel, division de GSK, passe un accord avec Welichem Biotech, Inc. pour l'acquisition d'un nouvel agent topique de traitement du psoriasis et de la dermatite atopique

 Stiefel, une division de GSK (NYSE:GSK) et Welichem Biotech, Inc. (WBI:CN) ont passé un accord pour l'acquisition par Stiefel de droits...

May 30, 2012, 20:47 ET

Stiefel, uma empresa GSK, sela acordo com a Welichem Biotech, Inc. para aquisição de um novo agente tópico para psoríase e dermatite atópica

Stiefel, uma empresa GSK (NYSE:GSK), e a Welichem Biotech, Inc. (WBI:CN), entraram em um acordo para aquisição, pela Stiefel, de direitos...

May 30, 2012, 20:34 ET

Stiefel, una empresa de GSK, celebra acuerdo con Welichem Biotech, Inc. para adquirir un nuevo agente tópico para el tratamiento de la psoriasis y la dermatitis atópica

 Stiefel, una empresa de GSK (NYSE: GSK) y Welichem Biotech, Inc. (WBI: CN) celebraron un acuerdo para la adquisición, por parte de...

May 30, 2012, 15:15 ET

Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis

 Stiefel, a GSK (NYSE:GSK) company, and Welichem Biotech, Inc. (WBI:CN), have entered into an agreement for the acquisition by Stiefel of...

Aug 08, 2011, 11:51 ET

Science Meets Nature in the First and Only Professional Line of ORGANICEUTICAL™ Anti-Aging Skin Care Products

The aging process involves more than just time and there are a variety of factors that contribute to this process which include sun exposure,...

Aug 01, 2011, 10:17 ET

One of Nature's Most-Potent Antioxidants Now Available in A New Anti-Aging Treatment

Stiefel, a GSK company, announces REVALESKIN® Skin Firming Serum, the newest addition to the REVALESKIN® family of products. Made with...

Jul 11, 2011, 10:17 ET

New Anti-Aging Treatment Arrives in Time to Give Consumers Added Product Protection This Summer

Stiefel, a GSK company, announces REVALESKIN® Illuminesse Brightening Complex, the newest addition to the REVALESKIN® family of...

Feb 04, 2011, 13:00 ET

Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter

Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United...

Jul 27, 2010, 09:00 ET

Stiefel, a GSK Company, Brings Acne Innovation Directly to Consumers with MaxClarity™

Stiefel, a GSK company, announced today that its new over-the-counter acne regimen is now widely available to U.S. consumers. The MaxClarity™...